The Department of Health and Human Services, Office of Inspector General (“OIG”) recently released a favorable advisory opinion, OIG Advisory Opinion No. 24-13 (the “Opinion”) to a pharmaceutical manufacturer (the...more
1/24/2025
/ Anti-Kickback Statute ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Fraud ,
Manufacturers ,
Medicaid ,
Medicare ,
OIG ,
Pharmaceutical Industry ,
Physicians ,
Travel Expenses
The Biden administration’s controversial Final Rule establishing minimum staffing requirements for nursing homes is under new attack. The Final Rule, long decried by nursing home industry leaders as a one-size-fits-all...more
10/17/2024
/ Centers for Medicare & Medicaid Services (CMS) ,
Health Care Providers ,
Healthcare Facilities ,
Healthcare Workers ,
Incentives ,
Labor Shortage ,
Long Term Care Facilities ,
Medicaid ,
Medicare ,
Nurses ,
Nursing Homes
On January 19, 2022, the Department of Health and Human Services, Office of Inspector General (“OIG”) released a favorable advisory opinion, OIG Advisory Opinion No. 22-01 (the “Opinion”), analyzing a proposed expansion of...more
2/15/2022
/ Advisory Opinions ,
Anti-Kickback Statute ,
Beneficiary Inducement ,
Civil Monetary Penalty ,
Customer-Loyalty Programs ,
Discount Pricing ,
Food & Drug Regulations ,
Low-Income Issues ,
Medicaid ,
Medicare Advantage ,
Medicare Part B ,
Medicare Part D ,
OIG ,
Patient Access ,
Pharmacies ,
Prescription Drug Coverage ,
Prescription Drugs ,
Remuneration ,
Sanctions ,
Statutory Interpretation